Literature DB >> 16194860

Platelets and tissue factor.

W Lösche1.   

Abstract

Tissue factor (TF) is the most important initiator of intravascular coagulation. This article will review published evidence on the contribution of platelets to TF exposure to the circulating blood. The following mechanisms will be discussed: decryption of monocyte TF by platelets, contribution of platelets to TF expression in leukocytes, platelet-derived TF and its procoagulant activity, and activation of circulating TF by platelets.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16194860     DOI： 10.1080/09537100500140190

Source DB:  PubMed          Journal:  Platelets        ISSN： 0953-7104            Impact factor:   3.862


  5 in total

1.  Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue Factor.

Authors:  Caroline S Gravastrand; Bjørg Steinkjer; Bente Halvorsen; Anne Landsem; Mona Skjelland; Eva Astrid Jacobsen; Trent M Woodruff; John D Lambris; Tom E Mollnes; Ole-Lars Brekke; Terje Espevik; Anne Mari A Rokstad
Journal:  J Immunol       Date:  2019-07-03       Impact factor: 5.422

2.  Microparticles profiling in trauma patients: high level of microparticles induce activation of platelets in vitro.

Authors:  Michael Caspers; Nadine Schäfer; Matthias Fröhlich; Bertil Bouillon; Manuel Mutschler; Ursula Bauerfeind; Marc Maegele
Journal:  Eur J Trauma Emerg Surg       Date:  2019-03-12       Impact factor: 3.693

Review 3.  Clinical significance of procoagulant microparticles.

Authors:  Shosaku Nomura; Michiomi Shimizu
Journal:  J Intensive Care       Date:  2015-01-07

4.  Longitudinal Dynamics of Coagulation and Angiogenesis Markers in Cancer Patients During and After Chemotherapy.

Authors:  Elina A Beleva; Tanya I Deneva; Snezhana S Stoencheva; Zhanet G Grudeva-Popova
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 5.  Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19.

Authors:  Mario Bautista-Vargas; Fabio Bonilla-Abadía; Carlos A Cañas
Journal:  J Thromb Thrombolysis       Date:  2020-10       Impact factor: 2.300
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.